Reply: Simplifying pharmacotherapy for patients with COPD: a viewpoint

Extract We have read the comments made by S. Suissa regarding the algorithm for COPD therapy that we recently proposed in our editorial viewpoint in the European Respiratory Journal [1]. As a statistician, he has concentrated on the possible confounders that support a lack of benefit on exacerbations and mortality when inhaled corticosteroids (ICS) are added to bronchodilators in COPD patients enrolled in clinical trials. He has done this over the years and indeed, he is the first author of all the six references supporting his argument in his correspondence.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Correspondence Source Type: research